Foresite Capital Management III’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-611,893
| Closed | -$12.8M | – | 12 |
|
|
2019
Q3 | $12.8M | Sell |
611,893
-35,361
| -5% | -$740K | 4.89% | 7 |
|
|
2019
Q2 | $13.5M | Hold |
647,254
| – | – | 4.42% | 7 |
|
|
2019
Q1 | $14.5M | Sell |
647,254
-62,568
| -9% | -$1.4M | 3.77% | 9 |
|
|
2018
Q4 | $17M | Sell |
709,822
-91,418
| -11% | -$2.19M | 5.58% | 7 |
|
|
2018
Q3 | $21.9M | Sell |
801,240
-49,973
| -6% | -$1.36M | 4.82% | 6 |
|
|
2018
Q2 | $22.9M | Sell |
851,213
-83,807
| -9% | -$2.25M | 4.93% | 6 |
|
|
2018
Q1 | $29.8M | Buy |
935,020
+170,196
| +22% | +$5.42M | 6.49% | 7 |
|
|
2017
Q4 | $28.9M | Sell |
764,824
-147,177
| -16% | -$5.57M | 8.12% | 5 |
|
|
2017
Q3 | $22.6M | Hold |
912,001
| – | – | 6.23% | 6 |
|
|
2017
Q2 | $18.8M | Hold |
912,001
| – | – | 6.13% | 5 |
|
|
2017
Q1 | $19.8M | Buy |
912,001
+8,111
| +0.9% | +$176K | 7.61% | 4 |
|
|
2016
Q4 | $18.5M | Sell |
903,890
-31,130
| -3% | -$637K | 8.03% | 4 |
|
|
2016
Q3 | $14M | Buy |
935,020
+700,000
| +298% | +$10.5M | 6.56% | 4 |
|
|
2016
Q2 | $2.54M | Sell |
235,020
-120,000
| -34% | -$1.3M | 1.74% | 14 |
|
|
2016
Q1 | $4.81M | Hold |
355,020
| – | – | 3.72% | 9 |
|
|
2015
Q4 | $6.55M | Buy |
+355,020
| New | +$6.55M | 5.81% | 6 |
|